Edition:
United States

Biocept Inc (BIOC.OQ)

BIOC.OQ on NASDAQ Stock Exchange Capital Market

0.19USD
18 May 2018
Change (% chg)

-- (--)
Prev Close
$0.19
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
427,491
52-wk High
$1.85
52-wk Low
$0.17

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.07 December 21 May 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 2 1.31 1.33 1.30 --
Quarter Ending Sep-18 2 1.64 1.69 1.60 --
Year Ending Dec-18 2 5.72 6.03 5.40 9.44
Year Ending Dec-19 1 9.05 9.05 9.05 --
Earnings (per share)
Quarter Ending Jun-18 2 -0.07 -0.07 -0.07 --
Quarter Ending Sep-18 2 -0.08 -0.07 -0.08 --
Year Ending Dec-18 2 -0.28 -0.28 -0.28 -0.70
Year Ending Dec-19 1 -0.22 -0.22 -0.22 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 1.10 0.81 0.30 26.84
Quarter Ending Dec-17 1.16 1.00 0.17 14.48
Quarter Ending Sep-17 1.42 1.11 0.31 21.93
Quarter Ending Jun-17 1.33 1.28 0.05 3.74
Quarter Ending Mar-17 1.32 1.68 0.36 27.60

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 1.31 1.31 1.31 1.90 --
Quarter Ending Sep-18 1.64 1.64 1.64 2.10 --
Year Ending Dec-18 5.72 5.72 5.72 8.82 9.44
Year Ending Dec-19 9.05 9.05 9.05 24.87 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings